Vandekop Amy O'Leary bought KLRS
August 27, 2026 · Form 4 insider transaction
Vandekop Amy O'Leary bought 10,000 shares of Kalaris Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
10,000
Price
$0.00
Total value
N/A
InsiderVandekop Amy O'Leary
RoleOfficer
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateAugust 27, 2026
Filing dateAugust 28, 2026
Shares owned after10,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option was granted on August 27, 2026. The shares underlying the option are scheduled to vest over four years, with 25% of the shares underlying the option vesting on August 1, 2027 and the remainder vesting in equal monthly installments thereafter, subject to continuous service.